Brief: Reviva Prices $18 Mln Public Offering Of Common Stock And Warrants
Dec 16 (Reuters) - Reviva Pharmaceuticals Holdings, Inc.
RVPH.O :
* ANNOUNCES PRICING OF $18.0 MILLION PUBLIC OFFERING OF
COMMON
STOCK AND WARRANTS
* OFFERING PRICE $1.50 PER SHARE WITH SERIES A AND B
WARRANTS
* PRICES PUBLIC OFFERING OF 12 MILLION SHARES
Source text: ID:nGNX1MQTHr
Further company coverage: RVPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reviva Pharmaceuticals Holdings
See all newsReviva Pharmaceuticals Q1 net loss narrows on lower expenses
Brief: Reviva Pharmaceuticals Holdings Inc - To Be Delisted From Nasdaq Trading Suspended As Of May 14, 2026 - SEC Filing
Brief: Reviva Reports Full Year 2025 Financial Results And Recent Business Highlights
Reviva Pharmaceuticals' 2025 net loss narrows on lower R&D spending
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture